Skip to main content
Caplight Logo









PharmNovo AB

PharmNovo AB

Private
LundHealthcare & Life Scienceshttps://www.pharmnovo.com/

Last Round

VC Round

Jul 9, 2026

Est. Valuation

$10.34M

Total Funding Raised

$5.23M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

PharmNovo AB is a clinical-stage pharmaceutical company that develops novel drug candidates for the treatment of neuropathic pain and other nervous system disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

neuropathic paindrug developmentdelta-opioid receptorbiotechclinical-stagepain managementsmall-molecule drugbiased signalingnon-addictive painkillerclinical trialsdrug discoverypharma licensingopioid alternativeCRO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

PharmNovo AB Comparables

Compare PharmNovo AB with similar companies based on industry and business-model similarity.

PharmNovo AB comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biodol Therapeutics
84%
Algiax Pharmaceuticals
83%
Confo Therapeutics
82%

PharmNovo AB Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 9, 2026
GrantJul 17, 2024
VC RoundJun 3, 2022
SeedOct 20, 2020

Key People

Founding team and executive leadership

Jesper Vallentin Kjerulff

Chief Operating Officer

Executive Team

PharmNovo AB Investors

Notable investors and investment history

PharmNovo AB investors
InvestorRounds
European Innovation Council FundGrant
Almi Invest ABSeed
ScietyVC Round, Seed
KDventures ABVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 51% MoM, reaching 1.6K.

  • Jul 9, 2026

    $4M raised in a VC Round.

PharmNovo AB Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

PharmNovo AB Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about PharmNovo AB's valuation, stock price, and market status.

Firmographic Details

HeadquartersLund
Employee Range11
Year Founded2008
Last FundingJul 9, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?